By Alexander Bueso
Date: Tuesday 14 Jul 2020
(Sharecast News) - Shares of US drug developer Rigel Pharmaceuticals shot higher on news that researchers at Imperial College were set to launch a clinical trial into the use of one of its existing treatments to help patients suffering from mild-to-moderate Covid-19 pneumonia from worsening.
No recent information was found.
Currency | US Dollars |
Share Price | $ 42.38 |
Change Today | $ 0.39 |
% Change | 0.92 % |
52 Week High | $43.72 |
52 Week Low | $10.40 |
Volume | 409,919 |
Shares Issued | 167.18m |
Market Cap | $7,084m |
RiskGrade | 262 |
Time | Volume / Share Price |
13:04 | 100 @ $42.38 |
13:04 | 100 @ $42.38 |
13:04 | 100 @ $42.38 |
13:04 | 100 @ $42.38 |
13:04 | 100 @ $42.38 |
You are here: research